Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine.
D000818:Animals; D000831:Animals, Newborn; D001692:Biological Transport; D001921:Brain / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D002250:Carbon Radioisotopes; D002499:Centrifugation, Density Gradient; D002852:Chromatography, Ion Exchange; D002855:Chromatography, Thin Layer; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000494:pharmacology*; D008680:Metaraminol / Q000494:pharmacology; D008856:Microscopy, Fluorescence; D008995:Monoamine Oxidase / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism; D014316:Tritium
D002250:Carbon Radioisotopes; D006892:Hydroxydopamines; D014316:Tritium; D012701:Serotonin; D008680:Metaraminol; D012110:Reserpine; D008995:Monoamine Oxidase; D009638:Norepinephrine